ARXX Therapeutics ApS — Credit Rating and Financial Key Figures
CVR number: 40868151
Hørkær 12 A, 2730 Herlev
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 2 129.48 | 2 396.65 | 5 789.92 | 2 790.58 | 2 608.21 |
| Costs of manufacturing | -7.91 | -2 635.78 | - 427.78 | -4.33 | |
| External services | - 464.42 | -13.65 | - 191.19 | - 208.51 | - 199.11 |
| Gross profit | 1 665.06 | 1 654.35 | 2 223.10 | 1 877.76 | 2 332.81 |
| Costs of management | - 720.74 | - 739.85 | - 276.53 | -71.95 | |
| Wages and salaries | -1 594.64 | -1 621.42 | -1 631.06 | -1 456.38 | -1 972.27 |
| Social security expenses | -12.03 | - 136.90 | - 185.28 | - 208.44 | |
| Other operating expenses | -58.39 | ||||
| EBIT | 32.94 | 455.14 | 236.09 | 152.10 | |
| Other financial income | 49.28 | 205.69 | 53.00 | 11.29 | |
| Other financial expenses | -3.34 | -4.86 | -9.97 | -13.60 | -10.72 |
| Pre-tax profit | -3.34 | 77.35 | 650.86 | 275.49 | 152.68 |
| Income taxes | - 143.75 | -5.73 | -35.95 | ||
| Net earnings | -3.34 | 77.35 | 507.11 | 269.76 | 116.73 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current amounts owed by group member comp. | 882.96 | 986.82 | |||
| Current other receivables | 131.59 | 7.66 | 105.31 | 24.55 | 16.15 |
| Short term receivables total | 131.59 | 7.66 | 105.31 | 907.51 | 1 002.98 |
| Cash and bank deposits | 287.40 | 721.18 | 1 067.70 | 313.11 | 348.42 |
| Cash and cash equivalents | 287.40 | 721.18 | 1 067.70 | 313.11 | 348.42 |
| Balance sheet total (assets) | 418.99 | 728.84 | 1 173.01 | 1 220.63 | 1 351.40 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Retained earnings | -11.38 | 495.72 | 765.48 | ||
| Profit of the financial year | -3.34 | 77.35 | 507.11 | 269.76 | 116.73 |
| Shareholders equity total | 96.66 | 177.36 | 595.72 | 865.48 | 982.21 |
| Non-current deferred tax liabilities | 61.46 | 9.95 | |||
| Non-current liabilities total | 61.46 | 9.95 | |||
| Current trade creditors | 1.11 | 0.72 | |||
| Current owed to group member | 122.44 | 436.57 | 226.76 | ||
| Short-term deferred tax liabilities | 229.15 | ||||
| Other non-interest bearing current liabilities | 199.89 | 113.80 | 120.67 | 293.69 | 359.24 |
| Current liabilities total | 322.33 | 551.48 | 577.29 | 293.69 | 359.24 |
| Balance sheet total (liabilities) | 418.99 | 728.84 | 1 173.01 | 1 220.63 | 1 351.40 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.